0000731012-23-000098.txt : 20230726 0000731012-23-000098.hdr.sgml : 20230726 20230726071134 ACCESSION NUMBER: 0000731012-23-000098 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230726 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230726 DATE AS OF CHANGE: 20230726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHCARE SERVICES GROUP INC CENTRAL INDEX KEY: 0000731012 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] IRS NUMBER: 232018365 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-12015 FILM NUMBER: 231110029 BUSINESS ADDRESS: STREET 1: 3220 TILLMAN DRIVE STREET 2: SUITE 300 CITY: BENSALEM STATE: PA ZIP: 19020 BUSINESS PHONE: 2159381661 MAIL ADDRESS: STREET 1: 3220 TILLMAN DRIVE STREET 2: SUITE 300 CITY: BENSALEM STATE: PA ZIP: 19020 8-K 1 hcsg-20230726.htm 8-K hcsg-20230726
FALSE000073101200007310122023-07-262023-07-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 26, 2023

HEALTHCARE SERVICES GROUP, INC.
(Exact name of registrant as specified in its charter)

Commission File Number: 0-12015
Pennsylvania23-2018365
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification number)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania
(Address of principal executive office)

19020
(Zip Code)

Registrant's telephone number, including area code: 215-639-4274
    
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

( ☐ )    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
( ☐ )    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
( ☐ )    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
( ☐ )    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueHCSGNASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 2.02Results of Operations and Financial Condition.

On July 26, 2023, Healthcare Services Group, Inc. (the "Company") issued a press release (the "Press Release") announcing its earnings for the three months ended June 30, 2023. A copy of the Press Release is being furnished hereto as Exhibit 99.1 and is hereby incorporated by reference to this Current Report.

The information furnished herein, including Exhibit 99.1 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01Financial Statements and Exhibits.

( a )    Not applicable
( b )    Not applicable
( c )    Not applicable
( d )    Exhibits.

Exhibit NumberDescription
99.1
104Cover page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HEALTHCARE SERVICES GROUP, INC.
Date: July 26, 2023By:/s/ Andrew M. Brophy
Name: Andrew M. Brophy
Title: Vice President, Controller & Principal Accounting Officer


 EX-99.1 2 ex99-2023xq2xpressrelease.htm EX-99.1 Document
Exhibit 99.1
Healthcare Services Group, Inc.
Reports Q2 2023 Results

Robust New Business Pipeline Sets Stage For
Second Half Of Year Growth

BENSALEM, PA --(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) reported for the three months ended June 30, 2023 revenue of $418.9 million, GAAP net income of $8.6 million, or $0.12 per basic and diluted common share, and adjusted EBITDA of $26.3 million.


Q2 Results

•Revenue for the quarter was reported at $418.9 million, with housekeeping & laundry and dining & nutrition segment revenues of $190.8 million and $228.1 million, respectively.
•Housekeeping & laundry and dining & nutrition segment margins were 8.7% and 5.5%, respectively.
•Direct cost of services was reported at $367.7 million, or 87.8%. Direct cost included an $11.3 million increase in CECL AR reserves.
•SG&A was reported at $41.4 million; after adjusting for the $2.3 million increase in deferred compensation, actual SG&A was $39.1 million, or 9.3%.
•The effective tax rate was 24.6%. The Company expects a 2023 tax rate of 24% to 26%.
•Cash flow from operations for the quarter was $7.4 million and was impacted by an $18.8 million increase in accrued payroll and a $39.0 million increase in accounts receivable related to the timing of cash collections. DSO for the quarter was 83 days.


Ted Wahl, Chief Executive Officer, stated, “In Q2, we delivered strong core earnings and added to an already robust new business pipeline, while navigating a difficult cash collections environment. Industry fundamentals continue to improve, and a stabilizing labor market and select state-based reimbursement increases have contributed to the gradual but steady occupancy recovery. While there remains uncertainty as to what a minimum staffing requirement might look like for the industry, we remain hopeful that CMS will fully consider the impact on operators before finalizing a rule, and have confidence in our customers’ ability to manage any such rule.”

Mr. Wahl concluded, “We enter the second half of the year with three clear priorities. The first is continuing to manage direct costs at 86%, excluding CECL. The second is collecting what we bill, building on the strong momentum gained in May and June. The third and perhaps the most impactful is the realization of our business development efforts yielding new facility starts. There is a high level of internal enthusiasm as we pivot to growth mode through the back half of 2023 and into 2024.”

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, July 26, 2023, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2023. The call may be accessed via phone at 1 (888) 330-3451, Conference ID: 4431380. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.


1

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the six months ended June 30, 2023; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2022 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting earnings before interest, taxes, depreciation and amortization ("EBITDA"), and excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking EBITDA and Adjusted EBITDA margin measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.


Company Contacts:
Theodore WahlMatthew J. McKee
President and Chief Executive OfficerChief Communications Officer
215-639-4274
investor-relations@hcsgcorp.com

2

HEALTHCARE SERVICES GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(in thousands, except per share data)
For the Three Months EndedFor the Six Months Ended
June 30,June 30,
2023202220232022
Revenues$418,931 $424,857 $836,161 $851,668 
Operating costs and expenses:
Costs of services provided367,728 379,370 728,706 752,632 
Selling, general and administrative41,429 29,281 81,476 65,017 
Income from operations9,774 16,206 25,979 34,019 
Other income (expense), net1,636 (7,956)2,987 (9,988)
Income before income taxes11,410 8,250 28,966 24,031 
Income tax provision2,812 1,430 7,684 5,882 
Net income$8,598 $6,820 $21,282 $18,149 
Basic earnings per common share$0.12 $0.09 $0.29 $0.24 
Diluted earnings per common share$0.12 $0.09 $0.29 $0.24 
Basic weighted average number of common shares outstanding74,478 74,337 74,488 74,332 
Diluted weighted average number of common shares outstanding74,567 74,358 74,543 74,345 

3

HEALTHCARE SERVICES GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
June 30, 2023December 31, 2022
Cash and cash equivalents$28,662 $26,279 
Marketable securities, at fair value93,185 95,200 
Accounts and notes receivable, net380,061 336,777 
Other current assets 47,178 50,376 
Total current assets549,086 508,632 
Property and equipment, net26,932 22,975 
Notes receivable — long-term30,740 32,609 
Goodwill75,529 75,529 
Other intangible assets, net13,539 15,946 
Deferred compensation funding37,020 33,493 
Other assets28,912 29,150 
Total assets$761,758 $718,334 
Accrued insurance claims — current$24,891 $23,166 
Other current liabilities164,773 155,453 
Total current liabilities189,664 178,619 
Accrued insurance claims — long-term68,920 65,541 
Deferred compensation liability — long-term37,171 33,764 
Lease liability — long-term11,560 8,097 
Other long term liabilities3,854 6,141 
Stockholders' equity450,589 426,172 
Total liabilities and stockholders' equity$761,758 $718,334 


4

HEALTHCARE SERVICES GROUP, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Unaudited)
(in thousands)

For the Three Months EndedFor the Six Months Ended
June 30,June 30,
2023202220232022
Reconciliation of Net Income to EBITDA and Adjusted EBITDA
Net income$8,598 $6,820 $21,282 $18,149 
Income tax provision2,812 1,430 7,684 5,882 
Interest, net488 (616)591 (1,033)
Depreciation & amortization3,595 3,618 7,315 7,765 
EBITDA$15,493 $11,252 $36,872 $30,763 
Share-based compensation2,351 2,372 4,409 4,768 
Gain/loss on deferred compensation, net
38 167 82 456 
Bad debt expense adjustments(1)
8,379 12,398 12,414 13,506 
Adjusted EBITDA$26,261 $26,189 $53,777 $49,493 
(1) The bad debt expense adjustment reflects the difference between GAAP bad debt expense (CECL) and historical write-offs as a percentage of revenues, both of which are based on the same seven year look-back period.

5
 EX-101.SCH 3 hcsg-20230726.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 hcsg-20230726_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 5 hcsg-20230726_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document
Jul. 26, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jul. 26, 2023
Entity Registrant Name HEALTHCARE SERVICES GROUP, INC.
Entity File Number 0-12015
Entity Incorporation, State or Country Code PA
Entity Tax Identification Number 23-2018365
Entity Address, Address Line One 3220 Tillman Drive
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Bensalem
Entity Address, State or Province PA
Entity Address, Postal Zip Code 19020
City Area Code 215
Local Phone Number 639-4274
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol HCSG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0000731012
XML 7 hcsg-20230726_htm.xml IDEA: XBRL DOCUMENT 0000731012 2023-07-26 2023-07-26 false 0000731012 8-K 2023-07-26 HEALTHCARE SERVICES GROUP, INC. 0-12015 PA 23-2018365 3220 Tillman Drive Suite 300 Bensalem PA 19020 215 639-4274 false false false false Common Stock, $0.01 par value HCSG NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document Sheet http://hcsgcorp.com/role/Document Document Cover 1 false false All Reports Book All Reports hcsg-20230726.htm ex99-2023xq2xpressrelease.htm hcsg-20230726.xsd hcsg-20230726_lab.xml hcsg-20230726_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hcsg-20230726.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "hcsg-20230726.htm" ] }, "labelLink": { "local": [ "hcsg-20230726_lab.xml" ] }, "presentationLink": { "local": [ "hcsg-20230726_pre.xml" ] }, "schema": { "local": [ "hcsg-20230726.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hcsg", "nsuri": "http://hcsgcorp.com/20230726", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hcsg-20230726.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document", "menuCat": "Cover", "order": "1", "role": "http://hcsgcorp.com/role/Document", "shortName": "Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "hcsg-20230726.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://hcsgcorp.com/role/Document" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0000731012-23-000098-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000731012-23-000098-xbrl.zip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

;M\CGQ9^YJK M6F%MZ!ZC .$A/[#T*7!$GTW6 $@3Y^ :\I'RHE.2]8'N-,M;,M-!9\IJ]SD) M)&5SJV?N-994])$F;9889E7#2@@=)^R@^.'0YPEVI0YX*!1=/'0H15O+>S/8 MT & G6*I-W^+>*&\G#<>6D[=;AG8>TB!T-0O7IRW)>JB+?%GZM^^9K?JKMZZ M\[)>-^Z\=M^P9KW5NOOJNJ/:5KVEW_WH[+!_"D9(9@"[$_ 7?WO5>K6PW.[ M'/\B1K'8;K:KM[G[W6)CE+A[SK85/#21#1C)_HX,]V%AF!++!J=O!B&\TA2AS3?Y>)]^\ M?S"V3!]W8Z:X3$&T?V0]8/FBQ7U6!ES[MVS?QUWNCWR^>ST MQW>-')]T5LKO7Y3^SNE)[_3K\5'[O'LTLVH(BUU _^FW;N5G\/9'2"'-AQ3[ M7?5I%46L*(,Q_$2LNF;C5'Q=77PK'1.9TM54W3'/-=-6RS;42R_NO M6>[FDV!#KSNM]895Q.X4L4V]L>JP2]!J879AA*OGG^[.%9.V34#QR@%.]R'' M*\#%IWRYQKE8=/]-+H+JXGJ-3:1_6\Z4'O]5EB5*"]=A>+'>;H]UK@0+=M![ M3F_-H5H:C0_@7B*:J02Y?[A5XL2%HRN(\N'9[A7+S,W6''>',4J7GD27*N)) M\2NR%W&4A7XMYX_G,388W,=SW#JB4I7+?".O9!5-?6B^BXKZT'.K::U.MH&/ MORTR<$.3GYVTV.VU4K.V#5=K689<&_XT',!+)3FA=%CI< D=-FW-;325#BL= MWEH==BU',QSEAY4.;[$.-PS-<=SMT>'*IB$#\6>KTI#3R0+T?",GL>!9?+5Q MR2K#-1FQ2B*MQMC9,2IKK\O+!L)3-2MNMYWBFY*WOH']% 6%R1AF.6XN#?O5 MBX"6T]2:YIH1L$)8;=?%U&QI5E-78JJVF,"2M*;N*#%57$P-4W,LLVIBJBQ8 M6 [NMP(L]!8V-%FRG\F3POS[#&@)6[?$@&Q#L\U62?NY1XN>RLWMMY3,EF:Z M90MT2DK/78,"6VJ6A0Q*2L\L):>AZ4;9ALV32ZFRB&$+5R4.F2 MPB-Z#-4SHI;6;-K;4VQ7@EU5L(:CF>NFO4JR59:LV=!:S;)(7TEV"R1KV8!H MMDBRE<4ZV]CZ%'MHY8< O\V;GN\T/!I854/*1S_-L50"5W$AO6UJK8;S3@FH MJ@(RM99;N01;"6G!BEH@);="5E195+"]%9#)%I+B-[%_I*J";!(N&)IMK-G* M5RE5E27K:F9#"78'!6NZ6LM1]:U=E*RMZ=OT9;+*XIWM7:.KQJCF&)55]>V% M]@#FY6)I/*/OI4']-D8+S34JMVQ0"6FQ'&M;:J5TQ874U!QWS:4 2DC/):2& MYKJ55A05;V <\86E>YWN*MM]#S^WG]Z?+3;[:#L+5&JVRWQTK-?\7[N8H M#=YU#78TURP+%I4&*PVNSJQ-0S-+HS2EPDJ%JS-KP]4,>\VOD^U!$;ZX97(. MPCUG!JV?PC[3&#/RLD H?I3AZ0NE-Q]5).X'B2K;WYR;_4@3[DV/BAW+8W1' M>%8W'IWR$B6 /8C06Q2']7KI[L:3+_!3*K?C*J=O_SX"2N6V2^5V8.L*I7); MIG)EFYU/KG(JB7WIW$:1N"CP5Q* MFY H2Y.4AC@]M4%3:68W;E9%EJ!Z#J2\EVE2U57TI6Z0,N M%%976%V1N!LD*JR^^9:30NO/%;L:CL*!U9>2U5 XL/I2:MB6DE+EI639C:I) MJ<)HO000*@/)-H*\U LW_L*]TT1UJ](.=>OV:<>?*07_!O_Z_.K#>_BK>&(F M'O^5)2D?W,@0S4.?A>E!2\Q"!OX^CI-C@,5AR#,MX?Z--':#^),*V]\Y$9DCV@D<7/#XY,<4[-/#=F_T9J MN?^W5]PWFJZN>[[GV;;M^FZ_KWLVZWM]T]4'NMGX/T-_53PTC*=:=,%J_9C1 MRQH=P 0/:'!-;Y)Y-HQX6%M@^R+'[I3J_PLWOX(:>;SE/GOJD\K#TDZC#(8PT_*D2M\X@(@!+(#.D[8 M0?'#8>%3>2A>+AXZ'-'X NPO]UYH>PMYC'B?O#PUR[HN33,O2^9OSB_7Q:6% M[$I>_]%'$.BL-^T#I=XUPOB19 MEUKT/-FZ^Y E"+7Z>Q8R8ND:,7736J&\NZM\.&(>$^5ORQ"\,.=XL0^;*G=H M,A3GR7OX _M/QJ]H '*Z=5Q*B9;/_!XVLWGR+BZ!+3W_:M?Q3%=SG#4W3%V9 M!T]=BGV@E:ET>4]TV=',C1_\NBE=WH>N\S<:7[(<.S,OBR%M9XE&:$H&E,<$ M0DUV]W<==[-/TK(TPZU7JFNZL>9!3A>#5KHO)6V25LUFFS[ M&/N0XGV/HS&0LB;UZYIF(9:N->T7K#6J-&\E*9F:\Y+[H^T#7/@< M1?XU#X(]PP;-AM8HO0^:P@9[)J5]P :RZLO#E(87'+&!+/&LGS!L;[PQ+*UA M;?_FB+LNI8;6LK>_^%MIIW#$!BR.&4YP-&9A0O&['V20W;\WP6X&(:NIZ:7/ M>E50X=D[Q)K=*ON-=045UH *CV@!;6_0,5VMM0.[P^^ZE%J:T5!+R)ZA'[S< M":A%WONQR+OI&%JS]"X^6];S5LJ\)\ILN)IEE=V@?E_[^W?OS#([XY?N_J]! MY3[$[K;GQ1ED]3Q,LIB&'B->0/DHF?0#\V5>CTF@=M3;;9%#,VW-;6W_DG:E M=%NE=)9F.&NN@E3UEW46Z ><]GD@OMZW9\48P[&U9E-M3UEU,34:FMUX03'M M[S+]Q_J&'5W*;;@MS7&JFNJIM?J/%W#3U1RCXML/5":7K_08*A]_]/K<[>WF M.J[64CWWRDNIH37L%RPT[$/.MWPE3H'O;M1*?OS"=ED=5*G@\Z_.:9;&W=7+ M!"OM*;XRFK"->X;MC4Z&H34 .FB^XB<,^ 39.YJ!!6+OD&0%)['B.JS\((8E2['V=A'EYAE4;4->;\GP MQKGTPM!-V8NREZ=UE^K-DJ9Y7E;Z^AKAY8CCKA;)F*B+.5[(V<<&:] M^J!..)OP=(M/.+-:0/]9MW-ZTCG^>MP^/SX]Z9'33^3D]*3VN=W^3CX=G[3A M6OLK^=9M]WZM,TKK:66?K.;BYI^QFW11N+O\PEE:8?_KRAZFU M6G6W8:YSEAK,P;);3W#HF=5Z@D//C+K1> IB&Y:[/<1N%6>?BEAGM;/OEJ<1 M+WL2L6D_TTG$K:H=6/>P7Q=(YE,4@U]GY'P8,T:^P?W#A'1#G_F;.,;O$5P9 M<=\/V MSI<=_E>5)B5.R[UL;J71S>JKD"VMB]7BP^5-&5UGA6B*MKO8IG2L> M4KK2A/>-<>8FC'%'>:.4Z@F5ZIEQY$:^5P7 VGSY(K48\8"G\#9O!7F<,2\* M/1YPN1HW&L"K4G(<>M&(D30BW8_'YT=MT45K^W]E2X5=9.7T%QG'T15/(&-_TBQ\-Q=BFYI;>O]KM5K^N1V;9EOJ&X\5%U)3 M<]PUMR!20GHN(34TMS0L?7(A518A;$O=[2Z$D+*8)0^KEF)Z+DMR-!TRZJ0#546#&QWN>"(C6/FY8W]-Z\M M]Y#0403T_5=\I"H'I3EJ:8W6"Y[OKH2TFI <8\WS?)20GJ]R8!G*DBHOI*93 M.2%5%BS,?V%Y]>\C5PI)+%_.\X@%?X_L-CZ\R&N'^Y K3K[:3L1HK'&:;2D& M5+QAKE1XZU78T,S&FBL[E HK%:[ K"U'51&-4*)$NR=@EUW M?U(EV"H+UM9L?=,GB2G!5D*P36?-7H>"1)O;Z7AV*\&Y+<:,.FXREG\FCG 7 MNPL^O[:('0$_4QZ^>6TW#X,H24@4$G_9B4SS:\?D'H=J<<7*68I:0%9Q"1E. MV4-:E(B>640[\#6Z'9>0W7"J)J**@(OG(D/=65$%V/BQ.JNC2SW?,ER^2&ZP MJXNJW0NYB8_4!Y#93PG[A?B2$2KV$!JQ,)T_4VGZEC&L^:)MTY7+9Z8ZV0T[65'!1:?WC[U0GS"0Q]^.Z@9 MEEY_@I4WC;K[8,/!O*_A8*S:<=@HV,Q82<;SHK0'>=KJ=K^_$*1A#GJ11 MC!,GUS%/62T:#!)"X3\R9C&J'KU@>(Y&S*Y8F+%$(V!O0_SD>LB](:$Q4H@K MU*-04)'0$?R%=Y,;1F,21-%E#3T%#L@CO_Q1K>J X46U:-Q]P/"?_B#@ 5%T !$ !H8W-G+3(P,C,P M-S(V+FAT;>U<_W?B-A+_O7^%SKUKD_=B8QL"V$GHHX3=I=U-2&B93'T9EF M&:9&?FJ<_D/7?_^Y^YZ9[:M5^!+IXPZ>H6:Y:#B5!S/ M#HX&;MFI5LJ.5]7+%:^B5\J>K7LV?/JUFF.RJM\O^_VCP*W2/NW;M>-:Q83& MGD7-JF6;98<&?4I-IX[=#B7P!SQ&JQI,,*-!XW3$)"5(5F=_COG-F=:*(PF*JU]/$^C;S[[. M-,DFLJ1FI-3X[KOO3B67(6L,_72@H_C-FET]+64_GI8RTEX<3!NG ;\AJ9R& M[$P+>)J$=.I&<<1@ 'SB8D4FLC]Y$+!(_0GE%[!Z!/>S_B>RR_IGFJ_#[$1T MA)08=YNPO@)<8V]".M!(QO:9!G)R^WS" KU/0]0R'IQI?=VVM<:;YOM>^[2T MT,,6';8CX&_:@AX%#3M1P":_LNF,?EEKF/"O5K9,RU[JI+3(H6!])AC,;KIB M8E"WW%1I 0R#*%US)4S'F9;R41*B2JC?A@)'N3 'QB0-@$1ID4;6_[S3? QI M/!;J2VFPF[.N&$+6B]^9XKOXX@%^]SD31-%G*Y=:J_/KHCSN-VX4/RU23T!< M<5!\P0H0\ASL9P/YT\V:CEIVOVPVS&!-U:*D^"XZ*2WP70AI)I72'04M@1IG MNHS2X0\9T/^B].9M)/+GE@1RZEFG^2U-5&Z=I0D%' M/%$" MG?&9TE:CAFG89\$+D^")$)+6MU/].^D#D[ B1CR M\Q%HW@6[)=UX1*,?CU*P&V V!>]G%5/^%W,M&P:H/F_S00,=M#4%$\ R#/OC M1>>Z?4YZU\WK=F]QS'LXVEZ[];';N>ZT>Z1Y<4[:O[?>-2_>MDGK\L.'3J_7 MN;S8>Q8^T73(HX&,HR-R;K0,0 S'%6?K8:]2LF?EMK:2VS>7W0]DDV[ZZ[%Z_/"[-C1;!U5BD8PH 6\:DQWS$ M.\0JDU@0Z_@@."1Q7Z'MO><#QCX67'*@V)[X0P "C#1]B>.WG')E:?PO:I+0 MZR(G79;$0I*#XIM1\+LLE83=8(PD5#$+#MU'+/0KYI3Z%IGT0RU:8U?QN'TA^^MJGEB5X]4\'7?4"PKT9Y,PB;VX$0-(V!^ M+%10X(X!N JLI6T-?;MLP%.,,>0%E!0R!.#[KMU\?_VNU>RV2:_=_:W3 N_Z MMGOY\>J(="Y:QE=;WJ?6VX/VA,(:1/Y17<6,;T)3DB;,1P@;$!X1+E,"JQ:T M5QR^5E/;BD@[SA(2,PC1X3+B%;K-9,@;!YUKI0G@I$"1"?0OC]54HB MJ0<#RRMXL0 5UT$\(4U2YA9_G!3Q9Q8QZZK1R8B* >!R+Y8R'KF(R6^8D-RG M8=Z)ZB\KGL-UP\P@NX380 9%SWFQH8I*,E@NJ]0-QUQ?;!K6VK(=D2VI(6?# M!LF@D,^TLE8T2&@0 +AT[61"+!#&DK3OBR>3S-.KIKE;V]:)@$J2$^I)\!RM M> R1_K05!XMN!=-+&'U*EHCX!NG,_DTO*$1IVMU.I^DO^4_D_\U MG73RY("OB"W:B:K6@*@>[$2]7%UO*EZ9?H,C4IJ(J#8&-"O('X 5TX!G KR6%09$BF=.5S6AY*R]:_- M->]R_36#0+ TS?_W'FA8Q=JK:8VR;9ODFH*B,0?%+YOFSCIJP9^7XCJ^G5EK1VO\S**4AFRTLU[4@KT45^ :N,K>;^@Y M+'-#U[&?J@AK,Q< FJ5$ .\\H2%A$XAO)>@+_ S+E+U2D/P-5N)5#)H2_H@E24C3(@VX,_OP3,F2(?,_J]0S3<#+@R=$ ._%$^*Q,+Y% MUK$0!43J^J^DST.T"3P% R$9S'B &>V4C\:AI!&+QVDX)2DH1-J?JI9Y@]@# M0= B#L"".UDJI3F$1M.BK!^'T#FV0^3!,9>3NMNE-9]:G';91DW:PD1^$ER" M"#%=-8[RD"!=!F!>'(<>!7E(F)69P:N@W7!JE,8VLYDL4^Y5@J.MXHD/M M>*+U$)?]/KKQS<1??83XH5?=O]/M@]IO50+=/O .-YN,K.XKF(Y.FHZ9>,2D MU)YD4LI,KQSXFTU*7O=PW4;84\_*'0N:.3TFP&TFJW:$E>+E3A#XFOF\%[-A M4*X8=GWW&P9V':;5V3E9-=KU3;?8A\CG)&1]0%:))"E8_8"@;IWD13).[I=L MGX/B0\8.-T@8_O_(!A!5:#2"R>W=*LE]YKU< L$G'FDJ65[ M:E7/G'D]VSZ'B>C)V/]\1/X)GL B"17DAH;CI33ZYIK^]ZP\."NY'^?-?Y.W80RX&5!> M"#B/?*#B,Y,/;PHO;0+N5;XC2Q]UH@!!.R/>E/@JE01P\S-8<:;V?^_E>7A* M8(B ^!&1#LA Q+=RB-@_P=P/34G ^M"%.JF492+,XP(-WTM#9.<-R^0 XK: MB'K+%)TN^/<2IY?[I? M6;\L(FFOF8)M]WX*.F\5F59&9IS4>G_P5-QLV3EQB@7'*5.U@-4\OXJWI+B*#[.;("A?U5TFFJE9[XML[3)B$AG!XVD$/!&%'7)*!4> MO#Z*(+!(?>X)&!Z+#7O4!M+ MP8O/3RY""_B>74Y%KZFP86LL!*:RL\LCZQ'B-O/]@E7G&D3/H]GE[GORYM'= M$R8+ZV'%?SVL!.M965YNWVQQO1279ME&W7S M,>SCS0:[Z^M4S^<\"E"PBV:R)FV2P_ZK#LUYRSU!4\0,#QB,WAYH^I1 M>U7/IP88$^UV\A\KF?78ZDO[&/W^\]SGI'LS%I*]>\4FCJ/>O9K\:4]4(B3/ M@QA#.=(:BVD*!(GS_+WR#RD)5/B("1DRS\7DN14(*A_(RIR6Z/VD[^LRF)99 M>58K^7RE#?-'NSE7:O5;QSU.F\OFM'-NKW>'E MMXJR_NF.;85&YT!6BZ?CG%S4J5,LQLTV(T'F!EF"0KB[)$2CPUI MV$>SAH24,68)<1TK,*&,\J MNJM$C"Y1G?S%4D)^@V!!;92J!V^/<)=;"O!S@"I_H*/D!,J*%Q*:\[-$E^J) M!+&KC?"7<)"GE#T2K5Z6;OP/4$L#!!0 ( ' Y^E;<.DS=C.TM1 #_7%G)GW9N,,=7JV[CMT#U(QP6?! M.(P#!)R*BO%F%MQ<7^*3X&P^&IU^P/CVT]4"70BZ[(%K="Z!:*C0BND6Z1;0 M3R'OV#U!WSNB:R%[C.>.=BZ&!\F:5J,D3E(/\U99G$!>3W.:X!-($IP9"1,@ M.3G":E1G.TC+!96)$.IWF,4QHG=+:.5VK0M$6 M>H),:5P5:S4+6JV'(HI6JU6X2D,AFRB)XW%T^V7QPT&#+;9C_.X O2YEY_%I M9,TE4>#A+57-$]P*5,@AI**/;*GQ-)D$B&@M6;G4<&EZ<@$U679Z%BSY[R7I M6,V@,@WOP+;T +!GUD0VH+^2'M1 *+P3<#Y"R/: ]8.0&O$7M+TFC/,\C]:V MJ@!M>K80E&@W"F\VP>&Q/>)Q@M-QN%95$/U5V$-'C"M-.(5C8AL)>]Z_R&%W MH\?EX'G'Y^"<*:!A(^ZC"IB[N=?#J[?@]H#MX3 FX5QHQ[>:K6X8&*_%1F%4 M-O'"9W\%M5^2%Y/_RHBXOX)(*D7WSCQ%@Q0#2,U [6^-<]!*J W;3"_V4_NK M(V5H,O&0%P$.K\":(T.!;K&KQ'/UPV"XREQ !YO>_,^%#Q*.+=Q0E'DNW$4? M6;_E7QL[8M4L\$]Y@*SZYNKSZR^+B_F$]?Z\QPIJQIF;N=C]Q@CO/A*[XVGT M'/[,T5)!]8W/W?EYA5OR%O('(B4=77;'\W9IO4G;*GT'MQL6':[81MY;0Z?8 M[/9\] A02P,$% @ <#GZ5C'&#&"4"@ $V$ !4 !H8W-G+3(P,C,P M-S(V7VQA8BYX;6S57&MOVS@6_=Y?HKMWP#XXU]?S[U?,G$W5VGAG>6* M%TIZ]TEQXQ4WROL]R_],OG/O8L8+G>5S $ZKMYUEMX]Y!ABLAZV?C5_ M$RFF0R8PB!3&@)I'@"O. .602,HHB['\Z?H-80$E+ X H3$%E,08Q-@\%&'( MH J$)D)71F=)^N>;\B;F"^49]])%]?#=R4U1W+Z93.[O[U\_Q/GL=99?3S"$ M9+(>?;(:_K U_IY4HQ%C;%*]^C1TD30--&;1Y(_?SB_%C9ISD*2+@J>BG&"1 MO%E43YYG@A<5ZWMQ>:TCRD=@/0R43P&$ 4&O'Q;RY/25YRWIR+.9^JJT5_[] M]O53ZY1L4HZ8I.JZ_&PO5)YD\K+@>7'.8S4SZ"MKQ>.M>G>R2.:W,[5^[B97 MNMGL+,]K5DN4K$2)@A+EW]LFF_2 ?R"\Q3;6 X"KW/U\*(R[./U\,+A7)D*H MXP/>F*8WY.6"^I#*H=;NTU2]H1\?\:&615;PV0#+XGF:#.'!W'#TVOUF<_5 ME 5^0'!(0(2A #0, L!9B '7DF.E!((83HNG-3U5*?AVN9Z^FF/W!"<.GA4M M"LW5(KO+Q7-NF\^:$I;)565VBR:IF7=QRU=O,"C+0F )_'2-T5N#]$J4;R?/ M_G0@<79T:F:C8B43-22SL@S(\I>N9V*OZ\^R6AC4E=\+)5Y?9]\GYJV3LMHJ M[X#R3J6F5H.3K8_M?;Y&R7.QA^/5B(G(3(5S6X :W3K/YG;N%)G=)[ZDS4QZ MXF6Y5+FI6AL<:%QW",=723%3T]#'OC %)@@E-\6D8 S$/I- TLB4D4P@S(FK M<-?&QR;:"I27:0_A?\3_]-9PW57[Q)Z]8KMPXEU2=C@\OT MI1M-$MT:XR[/WXT=DX3/LOG\+DV67=%BBGTE?Y!Q9L8Z\. EVI^^=5-ML<3#I[G1H M4[^[![J+N-S.F%W<9*GZ?#>/53Z-HAA'FD .8T ]0,)(BX(,!J.N,],SL7< M5K\OC8]-NA4^KP+H+1':RW:+N/V*[4/'D<7JP(234-M<[J31+6.#R;/-C4UE MMHYQ%^55SLN=W,O'>9S-IG'$H<12@AAQDU&I#X%Y2IIVE6,_9%)B1&T56;,\ M-CFNP'E+=/92K-.U7X>=23AVC6OGOY, &WWMI+ZZI<&DU^C INZ:![B+[D-: MF+KX4RJR_#;+J\1Z6?!"G65W:9$_GF5236,2J4CX!/A2!8 J'9KDR#DPCTBH M,*%(8%LI6LPW-H$N(7LUS#]Y%6I#L[="[I70[=5KP_M^31^8S2,K_1!$.H4! M!WHZ!0<;^X.%# =G-P.)R]NZAI?W4IIUM*CL?LDO\NQ[8MR9^@&!3/LQX R& MIN@F!$0H5@ %<21B7ZD816YQI7FBD0:4%=@-!:P!NX:1%GYMXT=_UH8)'!T( MZQ N=K/1(TZT&!XX0.QV;SLR[!GO'A(N6_;[*QA0:#%X@-P-X2L;>$ M[%68[:/#7JKW1XA#$GCD*-&+.Z= 84M*IV"QU_A@ ]\"QOIKK MZ0*&7TQ(F@H2(1V+$# ARGT"0@&#- (82P*1I#@@VC9:-,XPMA#Q=%';$J5G M8'HE3ONPT$SD_EC0FYXC!P!G9IQ$O]/[3DIOMCB8O'Q_AUEGC=YV6E]U2X.MJT8'-M=3\X"NS>6' MN.44B2U#B* RM*1QE@#AC4!H6+21S P_YA;;]DX MS]B2PZI36F/UEF"]%5K7OK*96MNVLC=APW25KEQU:"EW,M&CHVRV.W!#N=.Y M[7YR]_#>[>1F=T.)UN:_ J8H-#<,0A!AC8#4 0N(@#XFUOO6[=.,+01LM4$' MZ1U[=8U_D7[QZ(WBD5K$,32';FWA81K"RVR6B*0PP>0W4Y#F"9]-C=XYICH" M(570I'U* ).8@QB&G&E.(L:5];626^;')O5GA-X:HL.5DMOL[1=V/TZ.+&@7 M.MRNE&SUNMNUDMOFAKM:LM65VO62[:,ZM'OE+G*N>'6F20(1RE#%@"F( %6A M!A$3"(0(0S^"D>"A]>;NIN&Q2?.L.K PX!S/A6MD6;3&'2DX=F=LY[U;7]S@ M:K>V>-/0<%UQ _Q:4]ST>L\#UXML4?#9?Y+;:C5%B(HX\$. 4,@!1:4(>:2! MUE$0:BE0B*VO46Z?9FQ"?'EVN 3K&;2=KMAH9-:V(^[+US -L3-5W0]9&YGH M?\1:-_MC#E@;76L]7FT>W?V,Y,J\=8K]4#!".)#0W% B?1 %00@(Q4K$6F$8 M"M>CD=+PV"3^M.]?@G,_!JFXLC_]<&5@J$./G[9MHS8RCGLT^FGWWXMWJ$W3BQG&)KY5TEBA]"J8GL'IFEA?$FF;4WO0,TPZM6>F0QYM\;Y'"GUI<>#L MV>+0=N)L&^@NY/MIS"%B$,4 A7X **7,2!F;*IE&T&13C@BQ MWD&J61Z;<)_ >24Z>[G6Z=HOT\XD'%F>EOX[B;+1UTYBK%L:3(2-#FR*KWE MU^SY,9FMOT@6F,I4(!(!)E%D=*<(X$I!$"/!?45,]4H#M\3Y;'QLTEMEAA*@ M\S?PMHBS393=Z!@F1]HPT2$[;KO<(S%N&!LX)VZ[L9T.&\;TW#PJ-Z2^Y%?9 M?3H-H$88!0%@?HP!E;S\+IYD0(:(^CH06FK9:>?H>8Z12O1I+Z3:TMHFT.^N\3;=C\,9M$VTZU[A U#.TJ\"O^\$F: M%)[HU5?IUU^"+R^652P"2L<"4!R'(!9( Z/]D#!.=:BM2]^=,XU4[ :M5X?; M,3NW$6PK^P/0-HSXW1GK$ #VL-$C#+19'C@8['%P.R3L>T//S+_ZA%@@(A8FIRV6YM:4IB*)0(Z9H1&+'NKQAEI$&A*?Z!JX"K)GJ7@DT,=&_%JA9_3'50)-CK?5 X^##"1]/62@DY[&1.X,^ MH,H4 E$8Q2"2 8$"PE!)ZY^=:YWE+R7\J_NLO_!Q#^$[T?4CA;^+J8,('Q]% M^/C'"Q^["!_W%OY7=9V4W\-(B^KG387&2!*J 0Z0 C3F,>!2QB ,?1_ZF'/" M'#5?GV"D#<9-W+_\_35^IED^1OZIZ_^#U!+ P04 " !P.?I6 0/SELT& #Y,@ M%0 &ACZ.:1UNULD2-1(!O?RV!#W?WX\ M6_S8N*M-J+O%20JF"WYQ77;K1;<.B]^:]$?YV2S.*]/%)FT CH;#3IK+VU2N MUMV"$<:WW;9[TZ$*.N;:,5"!,1"X!288#<(0[H46VC+_C]4AUYG@VF; A14@ MN&5@&6ZZ/-35F7]QV'_84T;%CB\NATVW^ZON^[R<+F\OKX^N+&I M.FC2:LD(X/^E_SH3?56B^'O5^ZMN53'?&T=/G[SV>?W#IL#)1U MVYG:]0;:\K =&L\:9[I!]3_U:_%LCWX+MMV@;P+*@-.#F];O'^TM%G=RI*8* M'T-<]-^_?CS]8G+MVI5KTN6!:S;+?N=R&U_T=#BRN[T,;_?;A4];(V:7MD96RHAM;"A[(X:9#U8]MVR;BNR(B@PE,.,@Y,>0?6Y &4,=19 M&5U&OATT>MRBRT,4VN .5LWG)9YXV0O1_Q@4&=1X9.Y.EI?YO17D OL6D7L= M!5XGRF@%@E@**A-X*5BM.3.>$*(GN?VUM8=>?QW.X^063?(AX;RQ-6>2>Q#: MQ\3>]UA>FH0G KV5X=(#3EP7AK41=B 66A]S9+',^)SL XG\Z,8H1.7=&=J?S++"Y,#>G'N4K M8WFW\MCRSQUF13C=94P-LQ]'_ID!*1@/BCFBF-H!,,^8'X5*-G=4=J'M+" Y M]AY#T-Y_X8HMT$(+%8V)!+R7F"@)04#EQ@#7PF4F>N;#M/7&LZ9'P9'/'8ZI MFLX4#%8$&13.,@M,:\22L)F51*Y B^]>+_ @8;!8;Z_L#X:YK."8P3 M_/DA7337=1%]\*A*!,A+,4T;8.,B^(-$)&KW:1:#QM?5P=BWPG M=$R1=DZ(G#=M9ZI_EY=#2FU%L#C+*7"9P)68=1:4S"D8ED>AF5?:F=T!\L#V M.#QF7.?,VU>>-[V."AF7*GC -EQE7+G4K\VC>4 MX*[PIGA+F;THNRH47N-$%Z7'F!H4Q5#,D:728(S*B8[6<#8MN_S6XC@<9ERK MG"3A*X?_(IG^5<9/MQO;5(6U Y\6@@P:1*04M/8:!8<"!R)T$% M$2$*ICSF0)SH73R^>M+X.#!F7V^<+NPK\W&,&8[OLYSWE5D5VH1,4\% 6T]! M*&IQI1PU*$\4$](%FKE)1#PP-XZ!&9<<7R[>+&:%$_0\F>H4$]N;G\)M87$A MS+3A0*G'M-:3"#K3#C*&":]Q1+DPK=+PI-EQ%,RX^CA=S)W1\&;Y2,0S;#C: MN]_1?_3_E#C:^P]02P$"% ,4 " !P.?I68"$17"(@ #(R $ '0 M @ $ 97@Y.2TR,#(S>'$R>'!R97-S&UL4$L! A0#% @ <#GZ5@$#\Y;-!@ ^3( !4 M ( !BSP &AC